ArticleScientific reports2025
A hybrid CNN-ViT framework with cross-attention fusion and data augmentation for robust brain tumor classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Dual-Branch Frequency-Aware Attention Framework for Rare Neurological Disease Classification from Brain MRI.Diagnostics (Basel, Switzerland) · 2026Article
- A multi-level attention CNN-transformer based framework for the detection of brain tumor using regional dual-score explainability.Scientific reports · 2026Article
- NeuroPlast: a learnable activation function evaluated under knowledge distillation for medical image classification.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumor classification from MRI scans is a challenging task that requires accurate and timely detection increase patient survival rates. Conventional machine learning methods with hand-crafted features often fail to handle different sizes, forms, and textures of tumors. In this study evaluates, standard transfer learning models (AlexNet, MobileNetV2, InceptionV3, ResNet50, VGG16, VGG19) and conventional classifier models such as Decision Tree, Naïve Bayes, LDA were evaluated for multiclass brain tumor classification. The Vision Transformer (ViT) which leverages global context modeling achieved accuracy of 87.34%. To further improve performance, a hybrid CNN–ViT framework named CAFNet with data augmentation and a Cross-Attention Fusion mechanism achieving a test accuracy of 96.41% on a multiclass MRI dataset. The results show that CAFNet significantly outperforms conventional machine learning, deep learning and transfer learning models for robust brain tumor classification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.